Monalizumab | m-entrepreneurship.com

Product Name :
Monalizumab

Search keywords :
Monalizumab

drugId :
null

Target Vo:
NK cell lectin-like receptor subfamily C member 1

Target Vo Short Name :
KLRC1

Moa_Name:
NK cell lectin-like receptor subfamily C member 1 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Innate Pharma

Active Company_Name :
Astrazeneca Ab

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:
Colorectal Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Stathmin Rabbit mAb Cancer
Faricimab Cancer
Calponin 1 Antibody: Calponin 1 Antibody is an unconjugated, approximately 33 kDa, rabbit-derived, anti-Calponin 1 polyclonal antibody. Calponin 1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, sheep background without labeling.

Author: Betaine hydrochloride

Related Posts